Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 0.7% in the third quarter, HoldingsChannel.com reports. The firm owned 353,913 shares of the semiconductor company’s stock after buying an additional 2,421 shares during the period. Synopsys accounts for approximately 1.5% of Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s portfolio, making the stock its 21st largest holding. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Synopsys were worth $153,931,000 as of its most recent filing with the SEC.
Several other institutional investors have also recently added to or reduced their stakes in SNPS. Aries Wealth Management grew its stake in shares of Synopsys by 14.1% in the third quarter. Aries Wealth Management now owns 932 shares of the semiconductor company’s stock valued at $405,000 after buying an additional 115 shares in the last quarter. Kingswood Wealth Advisors LLC raised its holdings in shares of Synopsys by 35.4% in the 3rd quarter. Kingswood Wealth Advisors LLC now owns 1,225 shares of the semiconductor company’s stock valued at $533,000 after buying an additional 320 shares during the period. Paladin Wealth LLC raised its holdings in shares of Synopsys by 22.7% in the 3rd quarter. Paladin Wealth LLC now owns 1,328 shares of the semiconductor company’s stock valued at $578,000 after buying an additional 246 shares during the period. Robeco Schweiz AG raised its holdings in shares of Synopsys by 40.5% in the 3rd quarter. Robeco Schweiz AG now owns 36,800 shares of the semiconductor company’s stock valued at $16,006,000 after buying an additional 10,600 shares during the period. Finally, Citizens Financial Group Inc. RI lifted its stake in Synopsys by 39.2% during the 3rd quarter. Citizens Financial Group Inc. RI now owns 4,028 shares of the semiconductor company’s stock worth $1,752,000 after acquiring an additional 1,135 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts recently commented on SNPS shares. Needham & Company LLC raised their target price on Synopsys from $580.00 to $620.00 and gave the company a “buy” rating in a report on Monday, October 12th. KeyCorp lifted their target price on Synopsys from $600.00 to $605.00 and gave the company an “overweight” rating in a research report on Thursday, October 1st. JPMorgan Chase & Co. cut their price target on shares of Synopsys from $650.00 to $600.00 in a research note on Thursday, August 27th. Robert W. Baird raised shares of Synopsys from a “neutral” rating to an “outperform” rating and increased their price target for the stock from $558.00 to $560.00 in a research report on Thursday, August 27th. Finally, Rosenblatt Securities raised their price objective on shares of Synopsys from $575.00 to $620.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $575.00.
View Our Latest Stock Report on SNPS
Insiders Place Their Bets
In other news, insider Janet Lee sold 1,144 shares of the company’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total transaction of $574,882.88. Following the completion of the transaction, the insider directly owned 16,534 shares of the company’s stock, valued at approximately $8,308,665.68. This represents a 6.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the company’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total value of $4,585,000.00. Following the transaction, the chief financial officer directly owned 22,717 shares of the company’s stock, valued at approximately $11,358,500. This represents a 28.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 117,163 shares of company stock valued at $51,366,457 over the last quarter. Corporate insiders own 0.56% of the company’s stock.
Synopsys Price Performance
Synopsys stock opened at $430.14 on Monday. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The company has a fifty day simple moving average of $430.32 and a 200-day simple moving average of $443.50. The stock has a market cap of $82.43 billion, a P/E ratio of 76.00, a price-to-earnings-growth ratio of 1.75 and a beta of 1.21. Synopsys, Inc. has a 12-month low of $362.55 and a 12-month high of $539.48.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating the consensus estimate of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. Synopsys’s revenue for the quarter was up 42.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities analysts expect that Synopsys, Inc. will post 11.01 EPS for the current fiscal year.
Synopsys announced that its board has authorized a stock repurchase program on Monday, October 5th that allows the company to repurchase $1.00 billion in outstanding shares. This buyback authorization allows the semiconductor company to reacquire up to 1.1% of its shares through open market purchases. Stock buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.
Synopsys Company Profile
Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.
The company’s products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.
In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.
Further Reading
- Five stocks we like better than Synopsys
- Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Story
- Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader?
- Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Way
- Can Planet Fitness Get Its Growth Back in Shape?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
